Hemodynamics During the Soccer Championship 2012

July 2, 2012 updated by: PD. Dr. med Michael Reppel, University Hospital Schleswig-Holstein

Central Hemodynamics, Arterial Stiffness, Heartrate and Endothelial Dysfunktion During the European Soccer Championship 2012

The purpose of this study is to determine in soccer fans whether and to which extend positive or negative emotions during the European soccer Championship affects Central Hemodynamics, Arterial Stiffness, Heartrate and Endothelial Dysfunktion.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Anticipated)

180

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Germany
      • Hamburg, Germany
        • Universitätsklinikum Eppendorf
    • Bayern
      • Erlangen, Bayern, Germany, 91054
        • Universitätsklinikum Erlangen
    • Mecklenburg-Vorpommern
      • Greifswald, Mecklenburg-Vorpommern, Germany, 17475
        • Universitätsklinikum Greifswald
    • Schleswig-Holstein
      • Lübeck, Schleswig-Holstein, Germany, 23538
        • UKSH-Lübeck

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

primary care clinic, clinical employees, students

Description

Inclusion Criteria:

Best fit:

  • cardiomyopathy "severe myocardial disease leading to heart failure"
  • Angina, stable for at least 7 days
  • Myocardial infarction during 4 weeks before inclusion, actually stable condition
  • Angina, Stable, CCS II-IV

Exclusion Criteria:

  • not interested in soccer championship
  • age <18y
  • dementia
  • atrial tachycardia
  • drug/alcohol abuse
  • chronic kidney disease, stage 5
  • pulmonary/tricuspid valve insufficiency/stenoses
  • non compliant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital Schleswig-Holstein

Collaborators

Universitätsklinikum Greifswald, Greifswald, Mecklenburg-Vorpommern, Germany
Universitätsklinikum Erlangen, Erlangen, Bayern, Germany
Universitätsklinikum Eppendedorf, Hamburg, Germany
UKSH Campus Kiel, Kiel, Germany

Investigators

  • Study Director: Michael Reppel, PD. Dr. med, UKSH- Lübeck Medizinische Klinik 2

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2012

Primary Completion (Actual)

July 1, 2012

Study Completion (Actual)

July 1, 2012

Study Registration Dates

First Submitted

June 8, 2012

First Submitted That Met QC Criteria

June 9, 2012

First Posted (Estimate)

June 12, 2012

Study Record Updates

Last Update Posted (Estimate)

July 3, 2012

Last Update Submitted That Met QC Criteria

July 2, 2012

Last Verified

June 1, 2012

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HL-Med2-EM-2012

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Infarction

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe